cGAS inhibitors for Alzheimer's disease treatment
Más información
| Fecha de publicación: | 2021 |
| Objetivos: | ABSTRACT Alzheimer's disease (AD) is the most common form of dementia in elderly. Amyloid-β (Aβ) and tau pathologies and neuroinflammation are three major hallmarks of Alzheimer's disease. Vast majority of the drug discovery efforts in the past decades have focused on targeting the Aβ pathology, but |
| Año de Inicio/Término: | 2021-2025 |
| Financiamiento/Sponsor: | NIH |
| Rol del Usuario: | INVESTIGADOR(A) |
| URL: | https://reporter.nih.gov/search/obP95fHxCUe5W4z-qybM9w/project-details/11088880 |
| DOI: |
5R01AG074541-05 |